News
Eli Lilly’s Jaypirca (pirtobrutinib) has been shown to be superior to Johnson & Johnson (J&J) and AbbVie’s star Bruton's ...
Eli Lilly (LLY) has been actively progressing its pharmaceutical offerings and forging new alliances, as recent product results and collaborations indicate a commitment to innovation in Alzheimer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback